Skip to main content
Erschienen in: Clinical Neuroradiology 2/2023

01.06.2023 | Editorial

One Treatment to Heal them all: Thrombectomy also Benefits Stroke with Large Ischemic Core

verfasst von: Götz Thomalla

Erschienen in: Clinical Neuroradiology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Excerpt

Thrombectomy has revolutionized stroke treatment worldwide, improving the outlook for severe stroke with a treatment success previously unheard of in acute stroke treatment. Following the Dutch MR CLEAN trial [1], a series of clinical trials has demonstrated the benefit of endovascular thrombectomy (EVT) for patients with large vessel occlusion. In the pooled HERMES analysis of the “first wave” of stroke thrombectomy trials, the number needed to treat with thrombectomy to reduce disability by at least 1 level on the modified Rankin scale (mRS) at 90 days for 1 patient was as low as 2.6 [2]; however, in most of these trials enrolment excluded patients with large ischemic core, either based on the visual assessment of pre-treatment Alberta Stroke Program Early CT score (ASPECTS) or by quantification of the ischemic core using perfusion CT. Moreover, in the early trials the majority of patients were treated within the first 6 h of known symptom onset. As a result, most international guidelines adopted the recommendation for treatment with thrombectomy for large vessel occlusion within the first 6 h guidelines for patients with no signs of extended infarction, usually operationalized by an ASPECTS of ≥ 6. It took no longer than another 2 years until two further groundbreaking trials of stroke thrombectomy were published that challenged the strict time window: both, DAWN and DEFUSE‑3 randomized patients in a late time window up to 16 or 24 h after known onset or those with unknown time of symptom onset to treatment with EVT or usual care, if patients had a perfusion mismatch (DEFUSE-3) [3], or a mismatch between a severe clinical deficit and only a small infarct core (DAWN) [4]. In these highly selected patients, the treatment effect of EVT was even stronger than in previous trials but again, and on purpose, patients with already large ischemic infarcts were excluded from both trials. Therefore, until recently, the main open question regarding thrombectomy for stroke remained whether EVT is effective or useless in patients with already extensive ischemic stroke lesions. This question is answered now. …
Literatur
1.
Zurück zum Zitat Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.CrossRefPubMed Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.CrossRefPubMed
2.
Zurück zum Zitat Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.CrossRefPubMed Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.CrossRefPubMed
3.
Zurück zum Zitat Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718.
4.
Zurück zum Zitat Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.CrossRefPubMed Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.CrossRefPubMed
5.
Zurück zum Zitat Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large Ischemic region. N Engl J Med. 2022;386(14):1303–13.CrossRefPubMed Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large Ischemic region. N Engl J Med. 2022;386(14):1303–13.CrossRefPubMed
6.
Zurück zum Zitat Schroder J, Thomalla G. A critical review of Alberta stroke program early CT score for evaluation of acute stroke imaging. Front Neurol. 2016;7:245.PubMed Schroder J, Thomalla G. A critical review of Alberta stroke program early CT score for evaluation of acute stroke imaging. Front Neurol. 2016;7:245.PubMed
7.
Zurück zum Zitat Bendszus M, Bonekamp S, Berge E, et al. A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. Int J Stroke. 2019;14(1):87–93.CrossRefPubMed Bendszus M, Bonekamp S, Berge E, et al. A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. Int J Stroke. 2019;14(1):87–93.CrossRefPubMed
Metadaten
Titel
One Treatment to Heal them all: Thrombectomy also Benefits Stroke with Large Ischemic Core
verfasst von
Götz Thomalla
Publikationsdatum
01.06.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 2/2023
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-023-01304-z

Weitere Artikel der Ausgabe 2/2023

Clinical Neuroradiology 2/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.